Differences in the In Vitro Susceptibility of Planktonic and Biofilm-Associated Escherichia coli Strains to Antimicrobial Agents

被引:9
作者
Naves, P. [1 ,2 ]
del Prado, G. [1 ]
Ponte, C. [1 ]
Soriano, F. [1 ]
机构
[1] Fdn Jimenez Diaz, Dept Med Microbiol & Antimicrobial Chemotherapy, E-28040 Madrid, Spain
[2] Univ Estadual Goias, Unit Exact & Technol Sci, Anapolis, Brazil
关键词
Escherichia coli; biofilm; planktonic; Alamar Blue assay; in vitro susceptibility; PSEUDOMONAS-AERUGINOSA BIOFILMS; ALAMAR-BLUE ASSAY; ANTIBIOTIC-RESISTANCE; PENETRATION; DIFFUSION; BACTERIA;
D O I
10.1179/joc.2010.22.5.312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro susceptibility of seven Escherichia coli biofilm-producing strains in their planktonic and biofilm-associated forms to amoxicillin, amoxicillin/clavulanic acid, cefotaxime, gentamicin, and ciprofloxacin was studied. Minimum inhibitory concentrations (MICs) were determined by the standard microdilution method and by the Alamar Blue assay (providing the AB-MIC) at two levels of metabolic suppression and using standard and large inocula. Minimal biofilm inhibitory concentrations (AB-MBICs) on preformed biofilms on polystyrene plates were higher than the MICs and AB-MICs. Differences in magnitude depended on the antibiotic, strain, inoculum size, and the level of suppression of metabolism. Ciprofloxacin and gentamicin showed the greatest differences in the AB-MBIC as compared to AB-MIC. The possibility of antibiotic-resistant mutant selection within the biofilms was ruled out since bacteria recovered from the biofilm maintained the same MICs as before exposure to the antimicrobial agents. E. coli biofilms were much less sensitive than their planktonic counterparts.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 28 条
  • [1] Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa
    Abdi-Ali, A
    Mohammadi-Mehr, M
    Alaei, YA
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (03) : 196 - 200
  • [2] Anwar H., 1992, American Society for Microbiology News, V58, P665
  • [3] Aslam S, 2008, AM J INFECT CONTROL, V36, pS175e9
  • [4] Beloin C, 2008, CURR TOP MICROBIOL, V322, P249
  • [5] CLSI, 2006, informational supplement M100-S16, V26
  • [6] Biofilms: Survival mechanisms of clinically relevant microorganisms
    Donlan, RM
    Costerton, JW
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (02) : 167 - +
  • [7] High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms
    Flemming, Kristina
    Klingenberg, Claus
    Cavanagh, Jorun Pauline
    Sletteng, Merethe
    Stensen, Wenche
    Svendsen, John Sigurd
    Flaegstad, Trond
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 136 - 145
  • [8] ANTIBIOTIC INTERACTION AND DIFFUSION THROUGH ALGINATE AND EXOPOLYSACCHARIDE OF CYSTIC FIBROSIS-DERIVED PSEUDOMONAS-AERUGINOSA
    GORDON, CA
    HODGES, NA
    MARRIOTT, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (05) : 667 - 674
  • [9] MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides
    Hocquet, D
    Vogne, C
    El Garch, F
    Vejux, A
    Gotoh, N
    Lee, A
    Lomovskaya, O
    Plesiat, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) : 1371 - 1375
  • [10] Jiang XP, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P3